Recommendations for the use of first-line chemotherapy for the treatment of women with epithelial ovarian cancer

June 2014 | Incorporates published evidence to March 2014

A CLINICAL PRACTICE GUIDELINE DEVELOPED BY CANCER AUSTRALIA

This document supplements information about use of chemotherapy for women with epithelial ovarian cancer (Chapter 11) contained in the Clinical practice guidelines for the management of women with epithelial ovarian cancer, 2004.1

ISBN Online: 978-1-74127-282-6
© Cancer Australia 2014

Purpose

This guideline includes statements and recommendations based on available, high-level evidence about the use of first-line chemotherapy for the treatment of women with epithelial ovarian cancer. The guideline provides health professionals with information designed to assist in making management recommendations for improved patient outcomes. Cancer Australia also develops information specifically for consumers about ovarian cancer and treatment options.

Endorsed by:

Australia New Zealand Gynaecological Oncology Group
Australian Society of Gynaecologic Oncologists
Medical Oncology Group of Australia Incorporated
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists